Reports for EFAVIRENZ
Ingredient
EFAVIRENZ
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 300MG 200MG 600MG | TABLET | Resolved | 2022-06-03 | 2023-02-11 | 161940 |
| TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR | 600MG 200MG 300MG | TABLET | Resolved | 2020-04-16 | 2020-05-08 | 112370 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ATRIPLA | 300MG 200MG 600MG | TABLET | Discontinued | 2021-08-17 | 2022-01-01 | 144260 |
| SUSTIVA 200MG | 200MG | CAPSULE | Discontinued | 2021-06-14 | 2023-04-01 | 140881 |
| SUSTIVA 50MG | 50MG | CAPSULE | Discontinued | 2021-06-14 | 2023-04-01 | 140884 |
| SUSTIVA TABLETS | 600MG | TABLET | Discontinued | 2021-06-14 | 2022-10-01 | 140887 |
| TEVA-EFAVIRENZ | 600MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256134 |
Showing 1 to 5 of 5